Furthermore, extensive studies demonstrated that EZH2 could increase cancer proliferation, angiogenesis and invasion in different malignancies, including breast cancer [18], melanoma [19] and oral squamous cell carcinoma [20] among others. Here, EZH2 is linked to breast carcinoma.